TGFB1 and hepatocellular carcinoma: Coincidentally, we observed enhancement of several key fibrosis regulators in HCC patients compared to normal controls, including transforming growth factor beta (TGFB)1 (1.18-fold increase), platelet-derived growth factor (PDGF)A (5.02-fold increase), and PDGFB (2.019-fold increase).